Search results
Mouse study suggests cancer drug could be used to target protein connection that spurs Parkinson's...
Medical Xpress· 12 hours agoThe findings, published May 31 in Nature Communications, reveal how Aplp1 connects with Lag3, another cell surface receptor, in a key part of a process that helps spread harmful alpha-synuclein ...
Biotest wins FDA approval for plasma protein therapy
Pharmaceutical Technology via Yahoo Finance· 13 hours agoYimmugo is an intravenous immunoglobulin therapy developed as a substitution therapy for primary antibody deficiency syndromes. The Barcelona,...
Johnson & Johnson’s nipocalimab shows promise in Sjögren’s disease trial
Clinical Trials Arena via Yahoo Finance· 19 hours agoJohnson & Johnson announced findings from the Phase II DAHLIAS dose-ranging study where its...
Scientists use gene technology to develop possible antidote to black widow spider bite
United Press International via Yahoo News· 5 days agoPhoto by Adobe Stock/HealthDay News A potential human-specific antidote to black widow spider venom...
New antivenom invented for black widow spider bites
LiveScience· 6 days agoScientists have invented a new antivenom for European black widow spider bites that uses human antibodies to mitigate the effects of the arachnid's...
Ex CDC director predicts bird flu pandemic: What to know
The Hill· 10 hours agoFormer Centers for Disease Control and Prevention (CDC) Director Robert Redfield says it’s just a...
Exploring Hidden Gems on SEHK: 3 Stocks Estimated as Undervalued in June 2024
Simply Wall St. via Yahoo Finance· 6 hours agoAmidst a backdrop of fluctuating global markets, the Hong Kong stock exchange has shown resilience,...
New antivenom invented for black widow spider bites
Live Science via Yahoo News· 6 days agoA european black widow spider has a black body with orange blobs with white edges. The legs of the spider are black and brown striped. . Scientists have...
KRX Growth Companies With High Insider Ownership And At Least 26% Earnings Growth
Simply Wall St. via Yahoo Finance· 8 hours agoThe South Korean market has shown promising growth, rising 1.1% over the past week and achieving a...
...Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in...
WTNH-TV New Haven· 4 days agoStarting from molecular design, the unique approach of α bias with β and γ attenuated were...